CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI Early Rhythm-Control Therapy in Patients with Atrial Fibrillation Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus Lateral Wall Dysfunction Signals Onset of Progressive Heart Failure in Left Bundle Branch Block A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation

Original Research2021 Mar 25;cvab100.

JOURNAL:Cardiovasc Res. Article Link

Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics

DI Swerdlow, DA Rider, A Yavari et al. Keywords: lipoprotein(a)-mediated cardiovascular disease; treatment option; RNA interference therapeutics

Full Text PDF